Showing 1 - 7 of 7 Results for "opioids"

Results

Making opioid agonist treatment available in prisons can be effective in reducing HIV transmission.
Women Prisoners and Female Partners of Male Prisoners
3 studies Gray I, II, IIIb drug treatment, harm reduction, needles, opioids, prisoners Indonesia, Iran
Additional research is needed to assess which opioid agonist therapy is best for pregnant women. A Cochrane review assesses methadone as compared to buprenorphine and oral slow morphine, but only three trials were found with 96 pregnant women and further research is needed [See %{s:45}]
Women Who Use Drugs and Female Partners of Men Who Use Drugs
1 study
Interventions are needed to inform women who use drugs of harm reduction early in pregnancy and to ensure systematic access to opioid agonist treatment during pregnancy and in hospitals for birth and postpartum. Some studies have shown increased risk adverse health impacts as well as of vertical transmission among women who use drugs which may be mitigated by harm reduction [See %{s:45}]
Women Who Use Drugs and Female Partners of Men Who Use Drugs
1 study
(Metzger and Navaline, 2003 cited in Strathdee et al., 2006; Demaan et al., 2002 cited in Strathdee et al., 2006; Metzger et al., 2003 cited in Strathdee et al., 2006; Ball et al., 1988 cited in Strathdee et al., 2006; Bruce, 2010; Roberts et al., 2010).
Women Who Use Drugs and Female Partners of Men Who Use Drugs
10 studies Gray I, IIIa, IIIb, IV PWID, drug treatment, drug use, opioids, pregnancy, sexual partners, transmission Australia, Europe, Malaysia, Taiwan, United States
Women Who Use Drugs and Female Partners of Men Who Use Drugs
Prevention for Key Affected Populations
Despite injecting drug use being a main driver of the HIV epidemic in many parts of the world, evaluated tailored responses for women who use drugs or for female sexual partners of men who use drugs have not matched the needs of this population. Injecting drug use is globally widespread and the main driver of the HIV epidemic in some parts of the world. Approximately 16 million people in 148 co...
Adherence and Support
Treatment
"I'm 18 years, you are telling me drugs for life?" --Woman living with HIV in Uganda (Hsieh, 2013: 11)Treatment adherence is necessary to continually suppress the virus. Adherence to ART leads to better virological outcomes, prevents disease progression and improves survival (Nachega et al., 2010a; Nachega et al., 2010c). Conversely, inadequate adherence leads to drug resistance, which can then...
Increasing Access to Services
Prevention and Services for Adolescents and Young People
While the literature on access to HIV services by adolescents is limited, the literature on access to sexual and reproductive health services more broadly demonstrates that youth-friendly approaches can increase use of reproductive health care services by female adolescents (Gay et al., 2015). Young peoples service needs are frequently overlooked in HIV programming that is not specifically for ...